Mayo Clinic Q&A – Serology Testing for SARS-CoV-2 Antibodies
This episode is shared from Mayo Clinic Q&A and was recorded April 2020.
Guest: Elitza S. Theel, Ph.D.
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
A new serology test from Mayo Clinic Laboratories is being used to identify the presence of immune response to SARS-CoV-2, the virus that causes COVID-19. The serology test is intended only to detect antibodies to the virus. It does not diagnose recent or active infection. Mayo Clinic Laboratories also offers a molecular test to diagnose very recent or active infection. Both tests are important tools in the pandemic response.
On the Mayo Clinic Q&A podcast, Dr. Elitza Theel, director of Mayo Clinic’s Infectious Diseases Serology Laboratory, explains why serology testing is initially focused on identifying people in areas where potential immunity is key, including front-line health care workers.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
